- Always ≥ 99% purity
- Manufactured and sealed in a sterile environment
- Up to 70% more value in each bottle
- Each batch is independently double-tested
RAD-150 (TLB-150) is an esterified analog of RAD-140, structurally modified through the addition of a lipid-based ester moiety. This chemical modification confers increased molecular stability, extended in vivo half-life, and potentially enhanced bioavailability compared to its non-esterified parent compound. The ester linkage renders RAD-150 a prodrug form of RAD-140, facilitating a more gradual release profile and sustained activation of androgen receptors over time.

As a nonsteroidal Selective Androgen Receptor Modulator (SARM), RAD-150 retains the high affinity and anabolic signaling potential characteristic of RAD-140. The compound is under investigation in preclinical models for its capacity to support anabolic activity, improve tissue exposure kinetics, and engage androgen receptor pathways in a tissue-selective manner. These properties have led to its inclusion in research focused on musculoskeletal biology, molecular endocrinology, and neuroprotective mechanisms.
In experimental settings, RAD-150 has been associated with:
- Prolonged anabolic signaling attributed to its esterified structure, which may result in extended pharmacodynamic activity relative to non-esterified analogs.
- Induction of myogenic gene expression and hypertrophic activity in skeletal muscle tissue, with profiles comparable to or potentially exceeding those observed with RAD-140 under equivalent conditions.
- Facilitation of tissue remodeling and regenerative processes in muscle, particularly under simulated metabolic stress or injury-mimicking environments.
- Potential neuroprotective effects, likely mediated through selective activation of androgen receptors expressed in neuronal tissues.
- Low propensity for aromatase-mediated conversion to estrogenic compounds, based on observed structural stability and receptor selectivity in androgen-responsive assays.
As with other SARMs, RAD-150 demonstrates tissue selectivity, activating androgen receptors in muscle and bone while avoiding significant stimulation of the prostate or sebaceous glands. The extended duration may lead to greater hormonal suppression, which is an important consideration in endocrine-focused research.
⚠ Important Note: This product is supplied strictly for laboratory research use only. It is not approved for human consumption or therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions about RAD-150
RAD-150 (TLB-150) / Frequently Asked Questions
| Delivery - UK | Next working day |
|---|---|
| Delivery - Worldwide | 5-7 working days + customs processing time (varies) |
| Stock levels | Low |
| CAS Number | 1208070-53-4 |
| Molecular formula | C27H28ClN5O3 |
| Molar mass | 497.93 g/mol |
| Purity | ≥99% (see HPLC and COA documentation) |
| Concentration | 10 mg |
| Half-life | > 48 hours |
| Storage | 2 years at 20°C |
No lab reports available yet.
Be the first to review “RAD150 | 100 x 10mg” Cancel reply
Related products
GW0742 | 100 x 10mg
64,00 €LGD-3303 | 100 x 10mg
69,00 €







There are no reviews yet.